| 000 | 01889 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517002717.0 | ||
| 264 | 0 | _c20141215 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2014.14721 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKnoll, Greg A | |
| 245 | 0 | 0 |
_aLevofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. _h[electronic resource] |
| 260 |
_bJAMA _cNov 2014 |
||
| 300 |
_a2106-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntibiotic Prophylaxis |
| 650 | 0 | 4 |
_aBK Virus _xgenetics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aLevofloxacin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyomavirus Infections _xprevention & control |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTumor Virus Infections _xprevention & control |
| 650 | 0 | 4 |
_aUrine _xvirology |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aViremia |
| 700 | 1 | _aHumar, Atul | |
| 700 | 1 | _aFergusson, Dean | |
| 700 | 1 | _aJohnston, Olwyn | |
| 700 | 1 | _aHouse, Andrew A | |
| 700 | 1 | _aKim, S Joseph | |
| 700 | 1 | _aRamsay, Tim | |
| 700 | 1 | _aChassé, Michaël | |
| 700 | 1 | _aPang, Xiaoli | |
| 700 | 1 | _aZaltzman, Jeff | |
| 700 | 1 | _aCockfield, Sandra | |
| 700 | 1 | _aCantarovich, Marcelo | |
| 700 | 1 | _aKarpinski, Martin | |
| 700 | 1 | _aLebel, Louise | |
| 700 | 1 | _aGill, John S | |
| 773 | 0 |
_tJAMA _gvol. 312 _gno. 20 _gp. 2106-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2014.14721 _zAvailable from publisher's website |
| 999 |
_c24355716 _d24355716 |
||